Upstream Bio, Company Insiders
UPB Stock | 19.19 0.26 1.34% |
Upstream Bio, employs about 11 people. The company is managed by 11 executives with a total tenure of roughly 26 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Upstream Bio,'s management performance can provide insight into the company performance.
Upstream |
Upstream Bio, Workforce Comparison
Upstream Bio, is rated first in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 476,947. Upstream Bio, adds roughly 11.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Upstream Bio, Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of fifty-six. Upstream Bio, Price Series Summation is a cross summation of Upstream Bio, price series and its benchmark/peer.
Upstream Bio, Notable Stakeholders
An Upstream Bio, stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Upstream Bio, often face trade-offs trying to please all of them. Upstream Bio,'s stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Upstream Bio,'s stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
MD MPH | CEO Director | Profile | |
Maryse MS | VP Operations | Profile | |
Sumathi MD | VP Development | Profile | |
Parika MS | Head Operations | Profile | |
Allison Ambrose | General Counsel | Profile | |
Aaron MD | Chief Development | Profile | |
Fang Xie | Vice Biometrics | Profile | |
Mersedeh PharmD | Senior Quality | Profile | |
Adam MBA | Chief Officer | Profile | |
Lisa Fiering | Senior Culture | Profile | |
William Collins | Secretary | Profile |
About Upstream Bio, Management Performance
The success or failure of an entity such as Upstream Bio, often depends on how effective the management is. Upstream Bio, management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Upstream management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Upstream management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of Upstream Bio,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Upstream Bio,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Upstream Bio,'s management manipulating its earnings.
Upstream Bio, Workforce Analysis
Traditionally, organizations such as Upstream Bio, use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Upstream Bio, within its industry.Upstream Bio, Manpower Efficiency
Return on Upstream Bio, Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 |
Complementary Tools for Upstream Stock analysis
When running Upstream Bio,'s price analysis, check to measure Upstream Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio, is operating at the current time. Most of Upstream Bio,'s value examination focuses on studying past and present price action to predict the probability of Upstream Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio,'s price. Additionally, you may evaluate how the addition of Upstream Bio, to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Fundamental Analysis View fundamental data based on most recent published financial statements |